Another nice post 39KP Well said however we wouldn't have the cash burn due to P3 not in motion so to speak,money is in the kitty also a nice R&D kick back we will get.
As many have mentioned prior the dosage needs to be approved before we get any funding that's a no brainer.
AA with all the compelling data we have food for thought on a different pathway now wouldn't that be somthing to crow about.
Patience is required,unfortunately the FDA will take as long as they see fit.
Dam you PR for not having the power to pull leavers within the FDA.
Where we at?, page-45
-
- There are more pages in this discussion • 577 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |